Fumagalli, Giorgio Giulio
 Distribuzione geografica
Continente #
NA - Nord America 3.871
AS - Asia 3.633
EU - Europa 2.286
SA - Sud America 726
AF - Africa 95
OC - Oceania 19
Continente sconosciuto - Info sul continente non disponibili 2
Totale 10.632
Nazione #
US - Stati Uniti d'America 3.710
SG - Singapore 1.558
IT - Italia 913
CN - Cina 693
BR - Brasile 614
VN - Vietnam 522
RU - Federazione Russa 244
GB - Regno Unito 220
KR - Corea 172
DE - Germania 166
FR - Francia 157
LV - Lettonia 141
HK - Hong Kong 131
ID - Indonesia 118
BD - Bangladesh 111
IN - India 102
CA - Canada 93
FI - Finlandia 91
NL - Olanda 88
AT - Austria 76
IQ - Iraq 50
MX - Messico 45
AR - Argentina 35
JP - Giappone 34
PL - Polonia 27
ZA - Sudafrica 27
PK - Pakistan 26
EC - Ecuador 23
IE - Irlanda 23
ES - Italia 19
AU - Australia 18
TR - Turchia 17
GR - Grecia 15
HU - Ungheria 15
SA - Arabia Saudita 15
UA - Ucraina 13
JO - Giordania 12
MA - Marocco 12
BE - Belgio 11
CL - Cile 11
PT - Portogallo 11
SE - Svezia 11
VE - Venezuela 11
KE - Kenya 9
TN - Tunisia 9
CH - Svizzera 8
EG - Egitto 8
PE - Perù 8
PH - Filippine 8
PY - Paraguay 8
UZ - Uzbekistan 8
AE - Emirati Arabi Uniti 7
BO - Bolivia 7
DZ - Algeria 7
ET - Etiopia 6
JM - Giamaica 6
RS - Serbia 6
UY - Uruguay 6
IR - Iran 5
LB - Libano 5
OM - Oman 5
BG - Bulgaria 4
GE - Georgia 4
HN - Honduras 4
PA - Panama 4
SN - Senegal 4
AL - Albania 3
CI - Costa d'Avorio 3
CZ - Repubblica Ceca 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
KG - Kirghizistan 3
SY - Repubblica araba siriana 3
TH - Thailandia 3
TW - Taiwan 3
AZ - Azerbaigian 2
BN - Brunei Darussalam 2
BY - Bielorussia 2
CO - Colombia 2
CR - Costa Rica 2
GA - Gabon 2
GH - Ghana 2
IL - Israele 2
LK - Sri Lanka 2
LT - Lituania 2
LU - Lussemburgo 2
MD - Moldavia 2
MY - Malesia 2
QA - Qatar 2
RO - Romania 2
SI - Slovenia 2
TT - Trinidad e Tobago 2
XK - ???statistics.table.value.countryCode.XK??? 2
AD - Andorra 1
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
GM - Gambi 1
HR - Croazia 1
Totale 10.617
Città #
Singapore 976
Ashburn 682
San Jose 643
Trento 341
Dallas 272
Santa Clara 258
Columbus 239
Council Bluffs 230
Seoul 168
Ho Chi Minh City 158
Riga 141
Moscow 137
Hanoi 133
Hong Kong 127
Hefei 125
Los Angeles 123
Lauterbourg 114
Milan 96
Jakarta 94
New York 85
Nuremberg 78
The Dalles 75
Chicago 62
London 61
Washington 60
Beijing 58
São Paulo 58
Buffalo 55
Redondo Beach 54
Orem 46
Rome 44
Da Nang 43
Munich 42
Lappeenranta 40
Boardman 38
Helsinki 33
Salt Lake City 32
Frankfurt am Main 30
Tokyo 30
Amsterdam 29
Miano 25
Vienna 25
Haiphong 24
Montreal 22
Rio de Janeiro 21
Warsaw 21
Dublin 19
Guangzhou 19
Chennai 18
Baghdad 17
Belo Horizonte 16
Brooklyn 16
Curitiba 16
Shanghai 16
Denver 15
Paris 15
Tampa 15
Toronto 14
Turku 14
Budapest 13
Mumbai 13
North Bergen 13
Mexico City 12
Atlanta 11
Bassano del Grappa 11
Florence 11
Houston 11
Johannesburg 11
Phoenix 11
Biên Hòa 10
Brasília 10
Charlotte 10
Elk Grove Village 10
Manchester 10
Ottawa 10
Quito 10
Amman 9
Campinas 9
Erbil 9
New Delhi 9
Seattle 9
Tempe 9
Daiano 8
Dhaka 8
Imperia 8
Islington 8
Philadelphia 8
Porto Alegre 8
Tashkent 8
Athens 7
Bologna 7
Boston 7
Brisbane 7
Bến Tre 7
Cairo 7
Dongguan 7
Guarulhos 7
Kilburn 7
Nairobi 7
Pune 7
Totale 6.832
Nome #
Understanding Factors Associated With Psychomotor Subtypes of Delirium in Older Inpatients With Dementia 259
The search for a link between autism spectrum disorder and neurodegenerative dementia 240
The efficacy of cognitive stimulation, cognitive training, and cognitive rehabilitation for people living with dementia: a systematic review and meta-analysis 150
Tango and physiotherapy interventions in Parkinson’s disease: a pilot study on efficacy outcomes on motor and cognitive skills 137
Utility of visual rating scales in primary progressive aphasia 132
Parieto-occipital sulcus widening differentiates posterior cortical atrophy from typical Alzheimer disease 128
Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study 126
Mental State Recognition Deficits Linked to Brain Changes in Parkinson's Disease Without Dementia 125
Differential impairment of cerebrospinal fluid synaptic biomarkers in the genetic forms of frontotemporal dementia 120
The Italian guideline on diagnosis and treatment of dementia and mild cognitive impairment 117
Proteomic analysis reveals distinct cerebrospinal fluid signatures across genetic frontotemporal dementia subtypes 111
Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association study 108
Plasma glial fibrillary acidic protein is raised in progranulin-associated frontotemporal dementia 105
A data-driven disease progression model of fluid biomarkers in genetic frontotemporal dementia 104
Impairment of episodic memory in genetic frontotemporal dementia: A GENFI study 103
The inner fluctuations of the brain in presymptomatic Frontotemporal Dementia: The chronnectome fingerprint 99
Testing the 2018 NIA-AA research framework in a retrospective large cohort of patients with cognitive impairment: From biological biomarkers to clinical syndromes 99
Distinct patterns of brain atrophy in Genetic Frontotemporal Dementia Initiative (GENFI) cohort revealed by visual rating scales 97
MRI visual rating scales in the diagnosis of dementia: Evaluation in 184 post-mortem confirmed cases 97
CSF β-amyloid and white matter damage: A new perspective on Alzheimer's disease 97
Patterns of gray matter atrophy in genetic frontotemporal dementia: results from the GENFI study 95
Clinical Heterogeneity in Alzheimer’s Disease: A Possible New Amnesic Phenotype 95
Discrepant Views of Apathy in Patients and Caregivers: the Role of Cognitive Deficits in Parkinson's Disease 89
Association of Superficial White Matter Alterations with Cerebrospinal Fluid Biomarkers and Cognitive Decline in Neurodegenerative Dementia 89
Cognitive reserve and TMEM106B genotype modulate brain damage in presymptomatic frontotemporal dementia: A GENFI study 89
Examining empathy deficits across familial forms of frontotemporal dementia within the GENFI cohort 89
Temporal order of clinical and biomarker changes in familial frontotemporal dementia 89
Analysis of brain atrophy and local gene expression in genetic frontotemporal dementia 87
Diagnostic accuracy of research criteria for prodromal frontotemporal dementia 86
Predictor model for mild cognitive impairment in Parkinson’s disease using visual rating scales 85
Predominant right temporal lobe atrophy: Clinical, neuropsychological and structural differences based on amyloid status 85
Early neurotransmitters changes in prodromal frontotemporal dementia: A GENFI study 85
Faster Cortical Thinning and Surface Area Loss in Presymptomatic and Symptomatic C9orf72 Repeat Expansion Adult Carriers 85
A panel of CSF proteins separates genetic frontotemporal dementia from presymptomatic mutation carriers: a GENFI study 84
Amyloid PET imaging and dementias: potential applications in detecting and quantifying early white matter damage 84
Presymptomatic cognitive and neuroanatomical changes in genetic frontotemporal dementia in the Genetic Frontotemporal dementia Initiative (GENFI) study: A cross-sectional analysis 84
MRI data-driven algorithm for the diagnosis of behavioural variant frontotemporal dementia 83
MiRNA Profiling in Plasma Neural-Derived Small Extracellular Vesicles from Patients with Alzheimer's Disease 83
The Italian fund for Alzheimer's and other dementias: strategies and objectives to face the dementia challenge 82
Aquaporin-4 cerebrospinal fluid levels are higher in neurodegenerative dementia: looking at glymphatic system dysregulation 82
Extending the phenotypic spectrum assessed by the CDR plus NACC FTLD in genetic frontotemporal dementia 82
Profiling of specific gene expression pathways in peripheral cells from prodromal Alzheimer's disease patients 82
Association between enlarged perivascular spaces and cerebrospinal fluid aquaporin-4 and tau levels: report from a memory clinic 82
Anomia is present pre-symptomatically in frontotemporal dementia due to MAPT mutations 82
Comparison of arterial spin labeling registration strategies in the multi-center GENetic frontotemporal dementia initiative (GENFI) 80
Conceptual framework for the definition of preclinical and prodromal frontotemporal dementia 79
The potential of neurovascular modulation with tDCS: an exploratory analysis in older adults with hypertension. 79
Uncovering the heterogeneity and temporal complexity of neurodegenerative diseases with Subtype and Stage Inference 78
Teaching NeuroImage: Crowned Dens Syndrome: An Acute Attack of Calcium Pyrophosphate Deposition Disease Mimicking Acute Meningitis 78
Neuronal pentraxin 2: a synapse-derived CSF biomarker in genetic frontotemporal dementia 77
Word and Picture Version of the Free and Cued Selective Reminding Test (FCSRT): Is There Any Difference? 77
Functional network resilience to pathology in presymptomatic genetic frontotemporal dementia 77
Monozygotic Twins with Frontotemporal Dementia Due to Thr272fs GRN Mutation Discordant for Age at Onset 76
Impaired glymphatic system in genetic frontotemporal dementia: a GENFI study 76
The CBI-R detects early behavioural impairment in genetic frontotemporal dementia 75
The role of sex and education in the clinical manifestation and progression of Posterior Cortical Atrophy. 75
The Revised Self-Monitoring Scale detects early impairment of social cognition in genetic frontotemporal dementia within the GENFI cohort 75
The loss of macular ganglion cells begins from the early stages of disease and correlates with brain atrophy in multiple sclerosis patients 75
Plasma microglial-derived extracellular vesicles are increased in frail patients with Mild Cognitive Impairment and exert a neurotoxic effect 75
CSF glial markers are elevated in a subset of patients with genetic frontotemporal dementia 74
Social cognition impairment in genetic frontotemporal dementia within the GENFI cohort 73
Facing the digital divide into a dementia clinic during COVID-19 pandemic: caregiver age matters 73
Education modulates brain maintenance in presymptomatic frontotemporal dementia 72
Differential early subcortical involvement in genetic FTD within the GENFI cohort 72
Elevated CSF and plasma complement proteins in genetic frontotemporal dementia: results from the GENFI study 72
Data-driven staging of genetic frontotemporal dementia using multi-modal MRI 71
Altered plasma protein profiles in genetic FTD - a GENFI study 71
A Novel Automated Chemiluminescence Method for Detecting Cerebrospinal Fluid Amyloid-Beta 1-42 and 1-40, Total Tau and Phosphorylated-Tau: Implications for Improving Diagnostic Performance in Alzheimer’s Disease 71
Stratifying the Presymptomatic Phase of Genetic Frontotemporal Dementia by Serum NfL and pNfH: A Longitudinal Multicentre Study 70
Accuracy of the clinical diagnosis of dementia with Lewy bodies (DLB) among the Italian Dementia Centers: a study by the Italian DLB study group (DLB-SINdem) 70
Brain functional network integrity sustains cognitive function despite atrophy in presymptomatic genetic frontotemporal dementia 70
miRNA Expression Is Increased in Serum from Patients with Semantic Variant Primary Progressive Aphasia 69
Disease-related cortical thinning in presymptomatic granulin mutation carriers 69
Plasma Neurofilament Light for Prediction of Disease Progression in Familial Frontotemporal Lobar Degeneration 69
Caregiver Tele-Assistance for Reduction of Emotional Distress during the COVID-19 Pandemic. Psychological Support to Caregivers of People with Dementia: The Italian Experience 69
Network structure and transcriptomic vulnerability shape atrophy in frontotemporal dementia 68
Crossing Borders between Frontotemporal Dementia and Psychiatric Disorders: An Updated Overview 68
A modified Camel and Cactus Test detects presymptomatic semantic impairment in genetic frontotemporal dementia within the GENFI cohort 68
Motor symptoms in genetic frontotemporal dementia: developing a new module for clinical rating scales 67
Cognitive composites for genetic frontotemporal dementia: GENFI-Cog 67
Progranulin plasma levels predict the presence of GRN mutations in asymptomatic subjects and do not correlate with brain atrophy: results from the GENFI study 67
Modelling the cascade of biomarker changes in GRN-related frontotemporal dementia 67
Demographic, clinical, biomarker, and neuropathological correlates of posterior cortical atrophy: an international cohort study and individual participant data meta-analysis 67
An Automated Toolbox to Predict Single Subject Atrophy in Presymptomatic Granulin Mutation Carriers 66
Amyloid PET as a marker of normal-appearing white matter early damage in multiple sclerosis: correlation with CSF β-amyloid levels and brain volumes 66
Cerebellar and subcortical atrophy contribute to psychiatric symptoms in frontotemporal dementia 65
Practice effects in genetic frontotemporal dementia and at-risk individuals: a GENFI study 65
Language impairment in the genetic forms of behavioural variant frontotemporal dementia 65
NfL reliability across laboratories, stage-dependent diagnostic performance and matrix comparability in genetic FTD: a large GENFI study 65
Hierarchical spectral clustering reveals brain size and shape changes in asymptomatic carriers of C9orf72 64
Diogenes syndrome in dementia: a case report 64
Behavioral and neurophysiological effects of transcranial direct current stimulation (tDCS) in fronto-temporal dementia 62
Unravelling the Association between Amyloid-PET and Cerebrospinal Fluid Biomarkers in the Alzheimer's Disease Spectrum: Who Really Deserves an A+? 62
Characterizing the Clinical Features and Atrophy Patterns of MAPT-Related Frontotemporal Dementia With Disease Progression Modeling 62
Genetic forms of primary progressive aphasia within the GENetic Frontotemporal dementia Initiative (GENFI) cohort: comparison with sporadic primary progressive aphasia 62
White matter hyperintensities in progranulin-associated frontotemporal dementia: A longitudinal GENFI study 61
Cerebrospinal Fluid Level of Aquaporin4: A New Window on Glymphatic System Involvement in Neurodegenerative Disease? 61
Early onset behavioral variant frontotemporal dementia due to the C9ORF72 hexanucleotide repeat expansion: Psychiatric clinical presentations 61
Longitudinal cerebral perfusion in presymptomatic genetic frontotemporal dementia: GENFI results 61
Alzheimer's Disease Diagnosis: Discrepancy between Clinical, Neuroimaging, and Cerebrospinal Fluid Biomarkers Criteria in an Italian cohort of Geriatric Outputs: A Retrospective Cross-sectional Study 61
Totale 8.511
Categoria #
all - tutte 57.640
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 549
Totale 58.189


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/2023528 0 0 0 50 255 99 26 26 25 5 10 32
2023/2024977 5 12 77 30 78 215 159 91 10 87 68 145
2024/20252.778 62 31 140 473 118 375 67 79 412 342 307 372
2025/20266.792 236 152 749 1.000 870 446 1.220 183 523 727 288 398
Totale 11.075